Patent Expiration as a Decisive Factor of Pharmaceutical Firms’ M&As

  • Wed 11 Oct 17

    12:00 - 14:00

  • Southend Campus


  • Event speaker

    Marta F. Arroyabe

  • Event type

    Lectures, talks and seminars
    Management Science and Entrepreneurship Group

  • Event organiser

    Essex Business School

The Management Science and Entrepreneurship Group is delighted to welcome Marta F. Arroyabe to our seminar series to present her paper, titled 'Patent Expiration as a Decisive Factor of Pharmaceutical Firms’ M&As'.

Event abstract

This paper focuses on the importance of firms’ patent expiration rates on managers’ decision of engaging in M&As, in light of the innovation capabilities of the firm. While controlling for the usual M&As triggering factors, this study shows that indeed patent expiration is a good predicting factor of pharmaceutical firms’ M&As activity. The likelihood of firms’ engaging on M&As, in the event of patent expiration, is however negatively affected by the firms’ R&D efforts and basic research base. This study highlights the importance of innovation in pharmaceutical firms’ M&As’ decision and provides new lenses through which M&As can be studied, complementing the existing and scarce literature on the topic.

Speaker biography

Marta F. Arroyabe is a PhD student at the Center for Research in Economics and Management (CREA) at the University of Luxembourg (Luxembourg) and at UNU-MERIT (University of Maastricht, Netherlands). Her research interests include the areas of M&As, innovation roadmap, innovation planning, networks and alliances.

Related events